Corcept Therapeutics Executives Make Large Trades on July 1, 2025.

Corcept Therapeutics Inc. [CORT] reports that Chief Development Officer Guyer William has acquired 100 shares at $21.65 per share on July 1, 2025, and subsequently sold 100 shares at $73.51 per share on the same day. Chief Accounting & Technology Officer Lyon Joseph Douglas has also acquired 100 shares at $13.56 per share on July 1, 2025, and sold 100 shares at $73.51 per share on the same day. President of Corcept Endocrinology, Maduck Sean, has purchased 205 shares at $5.05 per share on July 1, 2025, and subsequently sold 205 shares at $73.45 per share on the same day.